Novonesis reports buyback transactions as Novonesis stock trades at EUR 62.00
Published on 10/20/2026 at 13:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBuyback activity and operating figures
- Novonesis reported buyback transactions on October 19, 2026.
- Organic sales growth reached 8.00 percent in the first half of 2026.
- Novonesis stock traded at EUR 62.00 at 1:30 p.m. CEST at Lang & Schwarz on October 20, 2026.
Novonesis (ISIN DK0060336014) was trading at EUR 62.00 at Lang & Schwarz on October 20, 2026 at 1:30 p.m. CEST. Marketscreener reported another transaction under the company's share buyback program on October 19, 2026.
Buyback activity continues
The latest transaction follows a broader capital-return program announced in September 2026. Marketscreener listed the first tranche at EUR 75.0 million and described the overall program as EUR 1.0 billion. That gives the transaction flow a measurable scale beyond a single dealing-day update.
What does the 37.70 percent margin show?
Novonesis reported 8.00 percent organic sales growth and a 37.70 percent adjusted EBITDA margin for the first half of 2026, according to IT Boltwise. The same report said the company raised its 2026 organic growth outlook to 7.00 to 8.00 percent from 5.00 to 7.00 percent, while retaining an adjusted EBITDA margin range of 37.00 to 38.00 percent. For investors, the comparison between the 8.00 percent first-half growth rate and the 7.00 to 8.00 percent full-year outlook points to execution against a more demanding target.
Three dates define the sequence
On August 26, 2026, Novonesis reported a second-quarter beat, raised guidance and announced a buyback, as listed by Marketscreener. On September 28, 2026, the first EUR 75.0 million buyback tranche began. On October 19, 2026, the company reported another transaction under the program.
The next reporting date is November 4
Marketscreener lists November 4, 2026 as the date for the third-quarter 2026 earnings release. That report will provide the next quantified test of the growth outlook and margin range.
Stock price stays the market anchor
The EUR 62.00 Lang & Schwarz price gives investors the immediate market reference, while the operating figures provide the business context. The buyback program, the 8.00 percent first-half organic growth and the 37.70 percent adjusted EBITDA margin are the main measurable factors framing the next report.
Novonesis was trading at EUR 62.00 at Lang & Schwarz on October 20, 2026 at 1:30 p.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Novonesis stock.
Novonesis stock facts
- Company: Novonesis A/S
- ISIN: DK0060336014
- Ticker: NSIS B
- Primary exchange: Nasdaq Copenhagen
- Price Lang & Schwarz (as of October 20, 2026, 1:30 p.m. CEST): EUR 62.00
- Sector / Industry: Specialty Chemicals
Market context: Latest market reports.
